Hepatitis B Virus Proteins Expressed by Recombinant Vaccinia Viruses: Influence of PreS2 Sequence on Expression Surface and Nucleocapsid Proteins in Human Diploid Cells

Overview

Journal Arch Virol

Specialty Microbiology

Date 1994 Jan 1

PMID 8279947

Citations 1

Authors

L Kutinova

S Nemeckova

E Hamsikova

H Zavadova

V Ludvikova

J Broucek

D Kunke

J Konig

L G Zakharova

G V Pashvykina

Affiliations

Soon will be listed here.

Abstract

Fifteen vaccinia virus (VV) recombinants derived from VV strains Praha, LIVP and DD (i.e. Dryvax Wyeth vaccine-derived) and expressing genes for S, preS2-S or c antigens of hepatitis B virus (HBV) were tested in monkey CV-1 cells and human diploid LEP cells. The production of infectious virus was found to be alike in all the recombinants and parental viruses as well. However, several recombinants produced markedly lesser amounts of S and preS2 antigens in LEP cells than in CV-1 cells. This reduction was independent of the parental virus used. There was, however, a relationship between the production of preS2 in CV-1 cells and the production of S and preS2 antigens in LEP cells; in general, recombinants efficiently inducing preS2 antigen formation in CV-1 cells produced markedly reduced amounts of S and preS2 antigens in LEP cells. Reduction of HBV antigen production in LEP cells was not apparent in recombinants expressing only S or c antigens of HBV, and the production of c antigen by double recombinants was not influenced by simultaneous expression of preS2 and S. The various recombinants also differed in the ratio of S:preS2 antigen formation. This difference seemed to be associated with the length of the untranslated leader sequence preceding preS2 but not with the parental virus or cell type used. The titers of antibodies against S and preS2 antigens induced in mice immunized with different recombinants differed markedly. The differences in the ratio of S:preS2 antigen production in vitro were not reflected in vivo by S:preS2 antibody ratio.

Citing Articles

Antitumor activity and immunogenicity of recombinant vaccinia virus expressing HPV 16 E7 protein SigE7LAMP is enhanced by high-level coexpression of IGFBP-3.

Musil J, Kutinova L, Zurkova K, Hainz P, Babiarova K, Krystofova J Cancer Gene Ther. 2014; 21(3):115-25.

PMID: 24556712 DOI: 10.1038/cgt.2014.6.

References

Kozak M . Effects of long 5' leader sequences on initiation by eukaryotic ribosomes in vitro. Gene Expr. 1991; 1(2):117-25. PMC: 5952206. View

Cheng K, Moss B . Selective synthesis and secretion of particles composed of the hepatitis B virus middle surface protein directed by a recombinant vaccinia virus: induction of antibodies to pre-S and S epitopes. J Virol. 1987; 61(4):1286-90. PMC: 254096. DOI: 10.1128/JVI.61.4.1286-1290.1987. View

Chelyapov N, Antonova T, Yanova N, CHERNOS V . Antigenic properties of vaccinia virus and of the virus recombinant strains expressing heterologous genes. Acta Virol. 1988; 32(5):409-16. View

Dubois M, Pourcel C, Rousset S, CHANY C, Tiollais P . Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA. Proc Natl Acad Sci U S A. 1980; 77(8):4549-53. PMC: 349881. DOI: 10.1073/pnas.77.8.4549. View

Mackett M, Smith G, Moss B . General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol. 1984; 49(3):857-64. PMC: 255547. DOI: 10.1128/JVI.49.3.857-864.1984. View

Slonim D, Hulenova M . Study of plaque titration of vaccinia virus in chick embryo cell cultures. I. Assays under an agar overlay. Acta Virol. 1969; 13(3):209-15. View

Joklik W . The purification fo four strains of poxvirus. Virology. 1962; 18:9-18. DOI: 10.1016/0042-6822(62)90172-1. View

Pasek M, Goto T, Gilbert W, Zink B, Schaller H, MacKay P . Hepatitis B virus genes and their expression in E. coli. Nature. 1979; 282(5739):575-9. DOI: 10.1038/282575a0. View

Paoletti E, Lipinskas B, Samsonoff C, Mercer S, Panicali D . Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. Proc Natl Acad Sci U S A. 1984; 81(1):193-7. PMC: 344637. DOI: 10.1073/pnas.81.1.193. View

10.

Nemeckova S, Kutinova L, Hamsikova E, Kunke D, Press M, Zavadova H . Synthesis and immunogenicity of hepatitis B virus envelope antigen expressed by recombinant vaccinia virus. Finding of retention signal in the C-terminal portion of the preS1 domain of subtype adyw. Arch Virol. 1991; 121(1-4):29-41. DOI: 10.1007/BF01316742. View

11.

Kutinova L, Nemeckova S, Hamsikova E, Press M, Zavadova H, Hirsch I . A recombinant vaccinia virus expressing hepatitis B virus middle surface protein. Restricted expression of HBV antigens in human diploid cells. Arch Virol. 1990; 112(3-4):181-93. DOI: 10.1007/BF01323163. View

12.

Smith G, Mackett M, Moss B . Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature. 1983; 302(5908):490-5. DOI: 10.1038/302490a0. View

13.

Chelyapov N, Rakhilina L, Antonova T, CHERNOS V, Grigorjev V, Chudakova E . Two vaccinia virus recombinants expressing HBsAg with different concentration of A- and pre-S2 antigenic determinants. Acta Virol. 1991; 35(5):413-22. View

14.

Cheng K, Smith G, Moss B . Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus. J Virol. 1986; 60(2):337-44. PMC: 288898. DOI: 10.1128/JVI.60.2.337-344.1986. View

15.

Hamsikova E, Zavadova H, Kutinova L, Ludvikova V, Krchnak V, Nemeckova S . Priming effect of recombinant vaccinia virus coding for the middle hepatitis B surface antigen. Arch Virol. 1990; 113(3-4):283-9. DOI: 10.1007/BF01316681. View

16.

Pourcel C, Louise A, Gervais M, Chenciner N, Dubois M, Tiollais P . Transcription of the hepatitis B surface antigen gene in mouse cells transformed with cloned viral DNA. J Virol. 1982; 42(1):100-5. PMC: 256049. DOI: 10.1128/JVI.42.1.100-105.1982. View

17.

McLachlan A, Milich D, Raney A, Riggs M, Hughes J, Sorge J . Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences. J Virol. 1987; 61(3):683-92. PMC: 254007. DOI: 10.1128/JVI.61.3.683-692.1987. View

18.

Bichko V, Pushko P, Dreilina D, Pumpen P, Gren E . Subtype ayw variant of hepatitis B virus. DNA primary structure analysis. FEBS Lett. 1985; 185(1):208-12. DOI: 10.1016/0014-5793(85)80771-7. View

19.

Standring D, Ou J, Rutter W . Assembly of viral particles in Xenopus oocytes: pre-surface-antigens regulate secretion of the hepatitis B viral surface envelope particle. Proc Natl Acad Sci U S A. 1986; 83(24):9338-42. PMC: 387133. DOI: 10.1073/pnas.83.24.9338. View

20.

Budkowska A, Riottot M, Dubreuil P, Lazizi Y, Brechot C, Sobczak E . Monoclonal antibody recognizing pre-S(2) epitope of hepatitis B virus: characterization of pre-S(2) epitope and anti-pre-S(2) antibody. J Med Virol. 1986; 20(2):111-25. DOI: 10.1002/jmv.1890200204. View